-
Diagnostics World Brief | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions
Jun 22, 2015
-
Diagnostics World Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.
Jun 22, 2015
-
Diagnostics World Brief | Strand Life Sciences announced an expanded StrandAdvantage pan cancer genomic profiling service. The new version of StrandAdvantage will include a panel that examines 152 genes and pathways known to be impacted by existing targeted solid tumor therapies.
Jun 1, 2015
-
By Bio IT World Staff March 30, 2015 | The New York Genome Center (NYGC) announced today that it has received approval from the New York State Department of Health to offer clinical whole exome sequencing for individuals with constitutional disorders.
May 27, 2015
-
By Bio IT World Staff April 13, 2015 | Roche is at it again. The pharma today acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening
May 27, 2015
-
May 14, 2015 | Mayo Clinic in Rochester, Minn., has announced plans to sequence genes from 10,000 patients for genetic variants that could affect their responses to a variety of medications, as part of a study that will track the long
May 27, 2015
-
By Bio IT World Staff May 27, 2015 | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next
May 27, 2015
-
February 19, 2015 | The Molecular Medicine Tri Conference is being held in San Francisco this week, and several updates and new products have emerged already. For live coverage of the event, follow @BioITWorld and the hashtag #TriCon on Twitter. Maverix
May 27, 2015
-
By Aaron Krol February 27, 2015 | Last week offered some brief sanctuary from snowy, subzero New England asBio IT World hit the 22nd annual Molecular Medicine Tri Conference in San Francisco, joining dozens of other Boston area professionals who navigated the ever
May 27, 2015
-
By Allison Proffitt May 21, 2015 | The CLARITY challenge is back, and calling for entries. Boston Children’s Hospital is launching the second iteration of the challenge—CLARITY Undiagnosed—focusing on identifying molecular diagnoses for five families with as yet undiagnosed conditions. Teams
May 27, 2015
-
January 28, 2015 | Cambridge, MA based Exosome Diagnostics aims to raise $25 million, on top of the $27 million in Series B funding it raised last March. Exosome would use the cash to launch its first two products a blood
May 27, 2015
-
February 10, 2015 | When it comes to high risk, infectious diseases, early detection can make all the difference in getting ill patients some much needed treatment. In some cases, it may even help stem an outbreak. This becomes incredibly critical
May 27, 2015
-
February 22, 2015 | Among Tech Review's top breakthroughs of 2015 liquid biopsy. Fast DNA sequencing machines are leading to simple blood tests for cancer. Availability now MIT Technology Review
May 27, 2015
-
By Aaron Krol September 23, 2014 | Nearly two months have passed since the FDA announced its intention to start regulating laboratory developed tests, or LDTs, by mid 2015. These tests, which are designed, made and performed entirely in a single
May 27, 2015
-
By Aaron Krol August 1, 2014 | On Thursday afternoon, the FDA announced that it plans, for the first time, to regulate laboratory developed tests in the same way it does other diagnostics. Up until now, this particular type of test
May 27, 2015
-
By Aaron Krol September 23, 2014 | Nearly two months have passed since the FDA announced its intention to start regulating laboratory developed tests, or LDTs, by mid 2015. These tests, which are designed, made and performed entirely in a single
May 27, 2015
-
By Aaron Krol January 2, 2015 | I came to the Simoa Accelerator, a small lab located inside the Quanterix headquarters in Lexington, Mass., at a good time the first experiment of the day had finished in the early afternoon, and
May 27, 2015
-
Bio-IT World | WuXi PharmaTech headquartered in Shanghai has acquired NextCODE Health of Iceland for $65 million in cash. The acquisition will merge the WuXi Genome Center with NextCODE to form WuXi NextCODE Genomics. The business will be headquartered in Shanghai.
May 27, 2015
-
Clinical Informatics News | Foundation Medicine of Cambridge, Mass., continues to make the case for expansive next generation sequencing (NGS) tests as the front line of cancer diagnostics, with a new publication in Clinical Cancer Research.
May 27, 2015
-
By Bio IT World Staff January 12, 2015 | Roche announced this morning that it has acquired a majority stake in Foundation Medicine. Roche will tender approximately $780m for 56.3% of the company and make an additional $250m investment by acquiring
May 27, 2015